CLEARSIDE BIOMEDICAL ($CLSD) posted quarterly earnings results on Thursday, March 27th. The company reported earnings of -$0.10 per share, missing estimates of -$0.10 by $0.00. The company also reported revenue of $310,000, beating estimates of $180,203 by $129,797.
You can see Quiver Quantitative's $CLSD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CLEARSIDE BIOMEDICAL Insider Trading Activity
CLEARSIDE BIOMEDICAL insiders have traded $CLSD stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CLSD stock by insiders over the last 6 months:
- NGAI HANG VICTOR CHONG (Chief Medical Officer) purchased 36,500 shares for an estimated $36,500
- CLAY THORP purchased 15,000 shares for an estimated $13,800
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CLEARSIDE BIOMEDICAL Hedge Fund Activity
We have seen 18 institutional investors add shares of CLEARSIDE BIOMEDICAL stock to their portfolio, and 28 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC removed 2,136,000 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $2,712,720
- FIRST MANHATTAN CO. LLC. removed 260,474 shares (-39.1%) from their portfolio in Q4 2024, for an estimated $247,450
- GCM GROSVENOR HOLDINGS, LLC removed 198,690 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $188,755
- UBS GROUP AG added 145,118 shares (+inf%) to their portfolio in Q4 2024, for an estimated $137,862
- ROSALIND ADVISORS, INC. removed 127,220 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $120,859
- ASSENAGON ASSET MANAGEMENT S.A. removed 125,190 shares (-48.7%) from their portfolio in Q4 2024, for an estimated $118,930
- MILLENNIUM MANAGEMENT LLC removed 91,019 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $86,468
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
